Wondering how the US markets performed in the middle of the day on Monday? Discover the movers and shakers of today's session in our comprehensive analysis.
October 6, 2025 – In a seismic shift that reverberated across both traditional financial markets and the burgeoning crypto ecosystem, Leap Therapeutics (NASDAQ: LPTX), a clinical-stage biotechnology company, today announced a landmark private placement deal. The $58.88 million to $58.9 million investment, spearheaded by prominent crypto investors Winklevoss Capital, is set to not only bolster [...]
Boston, MA – October 3, 2025 – Leap Therapeutics, Inc. (NASDAQ: LPTX) experienced a sharp downturn in its stock performance today, with shares falling by over 20% in intraday trading. This significant decline marks a notable correction for the biotechnology company, which had seen its stock surge dramatically in the preceding days,
Leap Therapeutics' Phase 2 trial data show sirexatamab boosts response rates and survival in MSS colorectal cancer, with ongoing business development plans.
